)
Deversify Health (DEV) investor relations material
Deversify Health Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Completed reverse acquisition of Deversify AB, with Euroafrica Digital Ventures AB renamed Deversify Health AB and new management appointed.
Divested subsidiaries, leaving no operations in Euroafrica Digital Ventures AB as of June 30, 2024.
Positioned to scale sales of existing products and develop new offerings, focusing on global digital presence and product innovation.
Financial highlights
Q2 2024 net revenue was 7.4 MSEK, up from 4.5 MSEK in Q2 2023; H1 2024 net revenue was 12.4 MSEK, up from 8.2 MSEK year-over-year.
Q2 2024 EBITDA was -0.2 MSEK (improved from -1.9 MSEK); EBIT was -1.1 MSEK (improved from -3.7 MSEK).
H1 2024 EBITDA was -1.1 MSEK (down from -0.1 MSEK); EBIT was -2.9 MSEK (improved from -3.9 MSEK).
Q2 2024 net loss was -1.4 MSEK (improved from -3.9 MSEK); H1 2024 net loss was -3.2 MSEK (improved from -4.1 MSEK).
Cash and cash equivalents at period end were 10 KSEK, down from 6,167 KSEK a year earlier.
Outlook and guidance
Company aims to intensify global marketing, expand digital presence, and further develop the Acetrack and Elitista platforms.
Plans to launch new breath analysis product and broaden educational offerings to more languages and markets.
Recent rights issue outcome exceeded expectations, supporting financial position for growth.
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)